Back

Reassessing the role of triglyceride-related residual risk based on recent evidence

13 April 2023 (16:40 - 16:50)
Organised by:
Congress Presentation Part of: New paradigms in the prevention of ASCVD: the role of EPA and triglycerides Lipids Open Access ESC Preventive Cardiology 2023

About the speaker

Photo
Professor Richard Hobbs

Oxford (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor F. Visseren (Utrecht, NL)
Slides Video
Presentation thumbnail
The benefits of icosapent ethyl in addressing residual risk: what is the evidence?
Professor L. Tokgozoglu (Ankara, TR)
Slides Video
Presentation thumbnail
Integrating icosapent ethyl in preventive strategies: practical guidance
Professor V. Aboyans (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion
Professor F. Visseren (Utrecht, NL)
Slides Video

Access the full session

Session thumbnail
New paradigms in the prevention of ASCVD: the role of EPA and triglycerides
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 16:40 CET
You may be interested in
thumbnail
Congress Session
Clinical scenarios addressing residual risk in atherosclerotic cardiovascular disease (ASCVD): understanding the role of triglycerides and eicosapentaenoic acid (EPA)
31 August 2024
thumbnail
Congress Session
Epidemiology of cardiovascular risk and disease
2 September 2024
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia
26 August 2023
thumbnail
Congress Presentation
Targeting triglycerides: is it worth it? lessons from recent trials
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources